Creators, makers, pioneers

About 12,000 employees, globally active and passionate about innovation — that is the way to achieve both market and technological leadership. We are Körber. Presenting our Group.

To overview

We are Körber

Körber is a leading international technology group that has around 12,000 employees all over the world. We are the home for entrepreneurs —we turn entrepreneurial thinking into customers success. Körber AG manages the Group and its five Business Areas: Digital, Pharma, Supply Chain, Technologies, and Tissue.

Insights

The Körber Insights shows the entire spectrum of the Körber world: We give our view of exciting developments and trends, as well as innovations and technologies. We also highlight personalities who drive Körber forward every day with their entrepreneurial spirit and new ideas.

Career

Career

Wanted: team players. The know-how, creativity, and dedication of our employees have made us a successful technology company in Germany and worldwide. Now we want to shape the future — with you! We offer exciting positions for experts, young professionals, university students, and high school students.

To CareerTo the Körber Group job market

"Modern leadership culture has a performance-enhancing effect"

A working climate that promotes innovation, diversity, and the courage to tell uncomfortable truths is more central than ever to a company's success today. In an interview, Gabriele Fanta, Head of Group Human Resources, explains how the new leadership principles at Körber specifically strengthen fruitful collaboration in everyday working life.

What comes after traineeship, Max?

Experience report: After graduating in mechatronics and mechanical engineering, Max Döring became a trainee at Körber. Today, he is Technical Product Manager at our Körber Business Area Pharma.

Sustainability report

Sustainability Report

The Körber Sustainability Report provides an overview of the main environmental, social and economic developments in the fiscal year 2021. We outline our most important activities by documenting what we have accomplished already.

To sustainibility

Procurement and Supply Chain Management

Procurement and Supply Chain Management

Joint future-proof activities are the foundation of sustainable procurement. Körber, as a globally leading technology group, therefore places great value on the optimal purchasing of materials and services.

To our Procurement and Supply Chain Management

Pharma

Digitization: On the path to Pharma 4.0

Körber’s Business Area Pharma is making the production operations of its customers more digital and thus more flexible. It does this by using smaller batch sizes and minimal delivery times or via networked industrial production processes.

Digital penetration, more and more individualized products and services, and the rapidly increasing significance of data have great potential. As a result, the manufacturing pharmaceutical industry is becoming the trailblazer for a personalized healthcare sector. Mass production is being made flexible. 

Using digitization

The pharmaceutical industry is undergoing a transformation. “Pharma 4.0” is the buzzword that sums up the digital advancement of the pharmaceutical industry. It stands for self-learning machines, a networked and more flexible production process, smart data management, and more intuitive forms of interaction between human beings and machines. In many areas, Pharma 4.0 is already a reality. We at Körber are conducting numerous projects to make digitization useful for our customers. The pharmaceutical companies are focusing on two major issues: networked production and ever smaller batch sizes as a result of personalized medicine.

lWith our supply on demand solution we’re already reducing supply chain costs by more than 50 percent for all companies, while maintaining top quality.r

Hans-Peter Süßlack, Business Process Manager at the Körber Business Area Pharma

In particular, the megatrend toward personalized medicine is having concrete and wide-ranging effects on packaging. “We are observing a continuous increase in the demands made on modern packaging systems. The broader range of product variants on offer is increasing the complexity of the production process. At the same time, the security and efficiency of processes are moving into the foreground,” says Dr. Mario Holl, Chief Digital Officer at the Körber Business Area Pharma. “Digital technologies help to meet these requirements.”

Pharmaproduktion: Der Trend geht zu kleinen Losgrößen.
Pharmaceutical production: There is a trend toward small batch sizes.

Small batch sizes and short delivery times

In our packaging material area of expertise, we at Körber offer “supply on demand” technology that enables our customers to deliver their products within five days at most, even with very small batch sizes and short order lead times. One of the factors that make this flexibility possible is the creation of direct connections. Our Rondo Solutions link their Enterprise Resource Planning (ERP) system with those of their customers. They also directly connect the digital printer for packaging labels with their customers’ facilities.

“This development is necessary because the market has changed greatly in recent years,” says Hans-Peter Süßlack, Business Process Manager at the Körber Business Area Pharma. In the past, a medication was produced in two or three basic forms. Today the market is much more fragmented because of the trend toward the individualization of medicine. For example, in the past a customer would simply order 250,000 packages of a medication. Today the same customer may order the same number of packages, but these are subdivided into 20, 30 or more different individual orders with batch sizes as small as ten or 20 items.

Automation with “supply on demand”

But it’s not only varied dosages and mixtures of medicines that are changing the sector. In addition, today the legal regulations often vary greatly in the countries where our customers sell their products. These different legal regulations and faster changes in marketing are creating one primary requirement: greater differentiation in the packaging to be printed. The diversity is increasing, because suppliers have to take into account a growing number of language and country versions as well as new requirements for serialization. 

The “supply on demand” solution, which integrates the ERP system and, even more importantly, automates work processes, saves costs for the customers. “With this solution we’re already reducing supply chain costs by more than 50 percent for all companies, while maintaining top quality,” says Süßlack. He expects to see further gains in efficiency in the future.

Networked industrial production

Efficiency improvements are also the focus of the second grand vision of Pharma 4.0: networked production. The production control software Werum PAS-X MES (Manufacturing Execution System) creates the preconditions for completely networked industrial production by means of an interface that quickly and easily integrates machines into the networks of pharmaceutical companies. “For a long time, this integration process was an unproductive task that took a lot of time,” says Klaus Sauermann, Senior Head of Business Development at the Körber Business Area Pharma. “Our plug & produce solution will greatly simplify this process in the future.”

Much like a USB interface, this solution enables a rapid exchange of data between Werum PAS-X and the machines in the customers’ production halls — it basically functions as a translator. “We ensure that the software and the machines speak the same language,” says Sauermann. PAS-X recognizes new machines in the network as relevant entities and provides them with all the data that is important for them, such as quantities and batch numbers.

lWe ensure that the software and the machines speak the same language.r

Klaus Sauermann, Senior Head of Business Development at the Körber Business Area Pharma

Experte für Plug & Produce-Lösungen: Klaus Sauermann, Senior Head of Business Development bei Werum.
An expert on Plug & Produce solutions: Klaus Sauermann, Senior Head of Business Development at the Körber Business Area Pharma.

Plug & produce in Industry 4.0

PAS-X offers many advantages for medication producers. It makes it easier to configure the production network and conduct qualification programs for employees. The likelihood of setup errors is reduced, and less time is required for completing projects. “All in all, it reduces the cost of integrating a new machine by up to 75 percent,” says Sauermann.

The plug & produce solution is open and completely independent of the supplier. Through Werum Solutions, we at Körber are working together with companies and organizations such as the International Society for Pharmaceutical Engineering (ISPE) to establish it as an industry standard. Says Sauermann, “Plug & produce is extremely important for Industry 4.0. Our interface is the perfect solution for this purpose.”

www.koerber-pharma.com

Related news

Tech

With data flowing, production is running

No need to fear Pharma 4.0: We are here to support customers shaping digitization tailored to their individual needs and capabilities.

Read more

Körber’s Werum PAS-X is an MES Leader in Gartner report!

Körber has been recognized a Leader in the 2021 Gartner Magic Quadrant for Manufacturing Execution Systems. Gain valuable insights into the MES market!

Read more
Tech

Keeping machines running

May we present: “Obsoletely”, an interactive portal for replacement parts. Our experts Lukas Jacob and Nizar Manzli from the Körber Business Areas Pharma and Digital explain how it works and helps customers prevent machine downtime.

Read more
People, Tech

Strong together: The recipe for success of the Business Area Pharma

How the Körber Business Area Pharma forges ahead with innovations for the pharmaceutical and biotech industries in a close dialogue with customers.

Read more
People, Tech

Inspection: Searching for air bubbles

Until recently, inspection cameras were unable to distinguish between harmless air bubbles and harmful foreign bodies in syringes and ampoules. An innovation from the Körber Business Area Pharma now immediately recognizes the difference between the two, and thus offers extensive benefits to the pharmaceutical industry.

Read more
Tech

Digitization: On the path to Pharma 4.0

Körber’s Business Area Pharma is making the production operations of its customers more digital and thus more flexible. It does this by using smaller batch sizes and minimal delivery times or via networked industrial production processes.

Read more
Tech

„We deliver the difference for patients."

Cell and gene therapy is considered a milestone in the fight against diseases. Dr. Judith Koliwer, Principal Consultant Cell and Gene Therapy Software...

Read more
Sustainability

Monomaterial solutions guarantee efficiency and sustainability

On top of the already high expectations placed on the pharmaceutical industry, there are also ambitious environmental sustainability goals.

Read more
Tech

Körber again positioned as a Leader

For the second year in a row, Körber is recognized as a Leader in the Gartner® Magic Quadrant™ for Manufacturing Execution Systems.

Read more
Back to top
Back to top